Literature DB >> 1711287

Localization of nuclear matrix proteins (NMPs) in multiple tissue types with NM-200.4 (an antibody strongly reactive with NMPs found in breast carcinoma).

N Weidner1, D S Weinberg, S C Hardy, K A Hollister, G P Lidgard.   

Abstract

Nuclear matrix proteins (NMP) are nonhistone proteins found in the nucleus of many eukaryotic cells. Furthermore certain NMPs are reported to be cell-type specific and expressed differentially by malignant cells. To study the specificity of NM-200.4 (an antibody reactive to NMPs extracted from cultured breast carcinoma cells of the T-47D line), cancers and benign tissues from multiple body sites were surveyed. All 17 breast carcinomas showed strong reactivity to tumor cell nuclei. Also nuclei from one of two lung carcinomas, a papillary thyroid carcinoma, an ovarian fibroma, and a lymphoma were strongly reactive. One leiomyosarcoma and a dermoid cyst were negative. Although 1 benign breast with duct hyperplasia showed moderate reactivity, only 1 of 10 benign breast biopsies without hyperplasia showed reactivity. Three of 4 skin biopsies, 2 liver biopsies, 6 of 9 kidney biopsies, and 5 of 10 gastrointestinal mucosal biopsies showed reactivity in benign nuclei. It is concluded that, although breast carcinoma nuclei showed the most consistent reactivity for NM-200.4, both benign and malignant nuclei from other body sites also show reactivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711287      PMCID: PMC1886386     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Nuclear protein matrix: association with newly synthesized DNA.

Authors:  R Berezney; D S Coffey
Journal:  Science       Date:  1975-07-25       Impact factor: 47.728

2.  Pre-mRNA splicing and the nuclear matrix.

Authors:  S Zeitlin; A Parent; S Silverstein; A Efstratiadis
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

3.  The association of transcribed genes with the nuclear matrix of Drosophila cells during heat shock.

Authors:  D Small; B Nelkin; B Vogelstein
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

4.  Nuclear matrix proteins reflect cell type of origin in cultured human cells.

Authors:  E G Fey; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  The nuclear matrix is the site of glucocorticoid receptor complex action in the nucleus.

Authors:  T M Kirsch; A Miller-Diener; G Litwack
Journal:  Biochem Biophys Res Commun       Date:  1986-06-13       Impact factor: 3.575

6.  Chromatin architecture and nuclear RNA.

Authors:  J A Nickerson; G Krochmalnic; K M Wan; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Association of globin ribonucleic acid and its precursors with the chicken erythroblast nuclear matrix.

Authors:  D A Ross; R W Yen; C B Chae
Journal:  Biochemistry       Date:  1982-02-16       Impact factor: 3.162

8.  Nuclear matrix DNA from chicken erythrocytes contains beta-globin gene sequences.

Authors:  P C Hentzen; J H Rho; I Bekhor
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Estrogen modulation of nuclear matrix-associated steroid hormone binding.

Authors:  R C Simmen; A R Means; J H Clark
Journal:  Endocrinology       Date:  1984-09       Impact factor: 4.736

10.  DNA is replicated at the nuclear cage.

Authors:  S J McCready; J Godwin; D W Mason; I A Brazell; P R Cook
Journal:  J Cell Sci       Date:  1980-12       Impact factor: 5.285

View more
  1 in total

1.  LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.

Authors:  Enza Piccolo; Nicola Tinari; Daniela Semeraro; Sara Traini; Imma Fichera; Albana Cumashi; Rossana La Sorda; Francesca Spinella; Anna Bagnato; Rossano Lattanzio; Maurizia D'Egidio; Annalisa Di Risio; Pavlos Stampolidis; Mauro Piantelli; Clara Natoli; Axel Ullrich; Stefano Iacobelli
Journal:  J Mol Med (Berl)       Date:  2012-08-05       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.